EyePoint Pharmaceuticals Inc (EYPT)
7.12
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
7.115
0.00 (0.00%)
After-Hours: 20:00
EyePoint Pharmaceuticals Profit Margin (Quarterly): -279.0% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cassava Sciences Inc | -- |
| Regeneron Pharmaceuticals Inc | 36.03% |
| Adverum Biotechnologies Inc | -2.71K% |
| Regenxbio Inc | -246.3% |
| Editas Medicine Inc | -101.9K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -50.67% |
| Return on Assets | -35.24% |
| Return on Invested Capital | -50.67% |
| Gross Profit Margin (Quarterly) | 93.01% |
| Operating Margin (Quarterly) | -311.2% |
| Return on Net Operating Assets | -340.5% |